Table II.
Multivariate analysis of the association between clinical indexes and survival time of patients with bladder cancer.
| 95.0% CI for HR | ||||||||
|---|---|---|---|---|---|---|---|---|
| Variable | Coefficient | Standard error | χ2 | df | HR | P-value | Lower | Upper |
| Age, ≥65 vs. <65 years | 0.022 | 0.010 | 4.633 | 1 | 0.0314 | 1.022 | 1.002 | 1.043 |
| Sex, male vs. female | −0.193 | 0.294 | 0.432 | 1 | 0.5112 | 0.824 | 0.463 | 1.467 |
| Muscle infiltration, T2-T4 vs. Ta-T1 | 1.140 | 0.304 | 14.092 | 1 | 0.0002 | 3.126 | 1.724 | 5.668 |
| Expression group, high vs. low | 0.832 | 0.267 | 9.690 | 1 | 0.0018 | 2.297 | 1.361 | 3.879 |
| Pathological tumor grade high vs. low | −0.951 | 0.410 | 5.386 | 1 | 0.0203 | 0.386 | 0.173 | 0.863 |
| Recurrence status, yes vs. no | −1.420 | 0.647 | 4.814 | 1 | 0.0282 | 0.242 | 0.068 | 0.859 |
df, degree of freedom; HR, hazard ratio; CI, confidence interval.